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Abstract
A number of biomedical devices require extended electrical communication with surrounding
tissue. Significant improvements in device performance would be achieved if it were possible
to maintain communication with target cells despite the reactive, insulating scar tissue that
forms at the device–tissue interface. Here, we report that the conducting polymer
poly(3,4-ethylenedioxythiophene) (PEDOT) can be polymerized directly within living neural
tissue resulting in an electrically conductive network that is integrated within the tissue. Nano
and microscale PEDOT filaments extend out from electrode sites, presumably forming within
extracellular spaces. The cloud of PEDOT filaments penetrates out into the tissue far enough
that it should be possible to bypass fibrous scar tissue and contact surrounding healthy
neurons. These electrically functional, diffuse conducting polymer networks grown directly
within tissue signify a new paradigm for creating soft, low impedance implantable electrodes.
(Some figures in this article are in colour only in the electronic version)
Introduction
Electrically responsive tissues including the brain, heart
and skeletal muscle provide a unique opportunity to couple
electronic devices and computers with human or animal
tissues making possible a therapeutic body–machine interface.
Hence, there is growing interest in development of implantable
electrode devices for diverse biomedical applications such
as retinal and cochlear prosthetics, deep brain stimulation,
cardiac pacemakers, drug delivery devices and biosensors.
The use of electrode devices in therapies for neurologic
deficits is being actively pursued with the hope of changing
the prognosis for individuals with spinal cord injury, sensory
or motor impairments and neurological disorders, including
chronic pain, Parkinson’s disease and epilepsy (Eisen and
Franck 2005, Patil et al 2004, Rodriguez-Oroz et al 2004,
Stieglitz et al 2005). However, major road blocks must be
overcome to make implementation of such devices possible,
including limited biocompatibility and bio-integration of
devices and electrodes, low-signal, non-specific interactions
at the neuron–electrode interface (Polikov et al 2005),
and the intellectual and technological challenge of joining
electronically and ionically conductive systems (Fromherz
2002).
Neural recording and stimulating devices communicate
with neurons via electrical signals and require direct, long-term
functional contact with the target tissue to operate properly.
Despite the privileged immunity of the central nervous system
(CNS), a foreign-body response is mounted which can result
in biofouling of the device, chronic inflammation, death
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of surrounding neurons and encapsulation of the device in
electrically insulating glial scar tissue (Biran et al 2005, Edell
et al 1992, Otto et al 2006, Rousche and Normann 1998,
Szarowski et al 2003, Turner et al 1999, Williams et al 1999).
Many research groups, including our own, have explored a
variety of tactics for overcoming the limitations of current
neural electrode devices, including attracting neurons closer
to electrode sites and reducing the immuno-reactive tissue
that forms around CNS implants. Schemes that have been
explored include the application of rejuvenating voltage pulses
(Johnson et al 2005, Vetter et al 2004), the development of
devices that release anti-inflammatory drugs or neurotrophins
(Jain et al 2006, Rathnasingham et al 2004, Spataro et al
2005, Williams et al 2005, Zhong and Bellamkonda 2005),
modification of device electrode sites with high surface area,
bioactive inherently conducting polymers (Cui et al 2003, Xiao
et al 2004) and devices comprised of soft polymers (Rousche
et al 2001) that buffer the tissue from inflammation-inducing
micromotion (Gilletti and Muthuswamy 2006, Kim and Martin
2006, Lee et al 2005, Subbaroyan et al 2005, Yang and Martin
2006). We now propose that it may also be effective to bring
the electrode out to the healthy neurons beyond the glial
scar. This would reduce the need to manipulate the brain’s
normal healing responses or coax neurons or their processes
toward the device surface. Here, we report the creation of a
nano and microscale conducting polymer network that can be
grown out from electrode sites of implanted devices using
in vivo electropolymerization of the inherently conducting
polymer, poly(3,4-ethylenedioxythiophene) (PEDOT). The
PEDOT filaments integrate directly within the surrounding
tissue and extend far enough out into the tissue that it should
be possible to bypass the typical neuronal ‘kill zone’ and glial
scar which have been estimated to range from 50 to 150 µm
(Polikov et al 2005).
Results and discussion
The generation of a conductive polymer network formed
within electrically active tissue signifies a new paradigm for
implantable electrodes. This research was in large part inspired
by our laboratory’s ongoing in vitro studies on the interactions
between cultured neural cells and PEDOT toward development
of a continuous electrode–neuron interface (Richardson-Burns
et al 2007) as well as by previous studies showing that PEDOT
and another conducting polymer, poly(pyrrole) (PPy), can
be electrochemically polymerized directly within low-density
hydrogels to form diffuse, filamentous conducting networks
(Brahim and Guiseppi-Elie 2005, Kim et al 2000, 2004,
Nyberg et al 2002). The possibility of polymerizing PPy
directly within a tissue has been previously explored in porcine
pericardium (Khor et al 1995). However, the resulting tissue–
polymer structures did not exhibit electrical functionality and
potentially cytotoxic chemical-initiated polymerization was
performed.
To begin investigations into whether living neurons could
be directly interfaced with PEDOT by polymerization with
the conductive matrix and still maintain relatively normal
physiology, we first assessed cytotoxicity of the EDOT
monomer and electrochemical polymerization procedures. We
found that cultured neural cells could be exposed to a 10 mM
EDOT solution (also containing 20 mM poly(styrene
sulfonate); PSS a poly-anionic dopant for PEDOT) while
maintaining at least 75% viability for as long as 72 h
(figure 1(a)) (Richardson-Burns et al 2007). Hence, the
monomer-associated cytotoxicity was negligible since typical
electropolymerizations had durations of 5–60 min. We
also found that electrochemical polymerization procedures
involving application of low electrical current (0.5–5 µA
mm−2) were compatible for use with the neural cells since
these currents did not produce unfavorable, irreversible
reactions such as hydrolysis. Studies using mouse dissociated
cortical neuronal cultures and SY5Y neuroblastoma-derived
neural cells seeded on metal electrodes indicated that PEDOT
could be electropolymerized around the cells resulting in live
neural cells embedded within a three-dimensional PEDOT
matrix (figure 1(b)). The morphology and topology of
the PEDOT polymerized in the presence of neural cells
cultured on electrodes were assessed using optical microscopy
(figure 1(c)) and scanning electron microscopy (SEM;
figure 1(d)). Prior to imaging the cells were formaldehyde
fixed and for SEM the cells were also dehydrated with
hexamethyldisilazane (HMDS). PEDOT formed on the
electrode surface and surrounded and partially embedded
the live cells and their extensions. The PEDOT was
optically opaque and appeared as a dark substance with cell-
shaped holes which resulted from polymerization of PEDOT
around the cells that were adhered to the electrode substrate
(figure 1(c)) (Richardson-Burns et al 2007). SEM revealed
the fuzzy, nodular nano and microscale surface morphology
typical of PEDOT and indicated that the polymer also formed
at the neural membrane–electrode interface and appeared
to use the cells, cell membranes and cell processes as
scaffolds for polymerization (figure 1(d)). The PEDOT
matrix surrounding the cells was found to be 1.5–4 µm
thick with variations due to the presence of the cells on
the electrode substrate. Interestingly, polymerization was
suppressed in regions directly beneath the cells themselves,
presumably because the cell membranes act as local barriers
to EDOT diffusion due to strong cell–substrate adhesions (see
figure 1(c)). We also found that the cell material could be
removed from the PEDOT-cell matrix to result in a biomimetic
conductive substrate containing cell-scale topological features
such as tunnels, troughs and caves. Ongoing studies are
investigating whether this kind of substrate on an implanted
device encourages cells in a host tissue to re-populate the cell-
shaped holes and send processes into the tunnels and crevasses,
making possible an intimate and specific electrical contact
between the electrode and target cells.
Using methods adapted from the experiments on PEDOT
polymerization in the presence of cultured neural cells,
we next established the experimental conditions needed to
electrochemically deposit PEDOT directly into brain tissue
from electrodes implanted into mouse brain slices (1–4 mm
thick). The tissue slices were physically stabilized during
electrode insertions and electropolymerization procedures





Figure 1. PEDOT can be polymerized in the presence of living neural cells resulting in a cell-templated, biomimetic conducting polymer
matrix. (A) Time course of cell viability following exposure of SY5Y neural cells to increasing concentrations of EDOT monomer solution
(0.001–0.1 M EDOT with 0.02 M PSS in PBS). Cell viability was determined by MTT assay using three independent cell samples for each
time point and each concentration. (B) Diagram representing the process of electrochemical polymerization in the presence of living cells
cultured on an electrode substrate. (C) Optical micrograph of PEDOT (dark substance) polymerized around live cells of mouse dissociated
cortical neuronal cultures. The PEDOT intimately contacts the cell membranes revealing neurites, filopodia and nanoscale cellular
processes. (D) Scanning electron micrograph (SEM) of PEDOT polymerized around neural cells reveals cell-shaped holes in the PEDOT
matrix as well as cell-templated caves, tunnels and troughs. The nano and microscale fuzziness and roughness that is characteristic of
PEDOT topology is also revealed by these SEM images. All cells were formaldehyde fixed prior to imaging and for SEM cells were also
dehydrated with hexmethyldisilazane (HMDS).
buffered saline, PBS) (figure 2(a)). In order to stimulate
PEDOT formation via electrochemical polymerization, EDOT
monomer must be near the active electrode. Therefore, 0.01
M EDOT monomer (in PBS that also contained 0.02 M PSS)
was delivered to the electrode sites within the brain slice in
one of two ways; monomer solution was allowed to passively
diffuse into the entire slice by submersion (10–20 min
at room temperature) prior to electrode insertion or the
monomer solution was injected by 29 gauge needle directly
into the vicinity of the electrode tip after insertion. The
working/stimulating electrodes (WE/SE) used for this study
were single Teflon-coated gold microwires (75 µm diameter)
with 1 mm of exposed, bare wire at the tip. A platinum
wire reference/counter electrode (RE/CE) was then placed
into the gelatin matrix or brain tissue, 10–20 mm away
from the tip of the WE/SE (see figure 2(a)). Galvanostatic
current (0.5–5 µA mm−2) was delivered using an Autolab
Potentiosta/Galvanostat (EcoChemie, The Netherlands). The
polymer first deposited on the electrode tip itself and then grew
out into the tissue forming a diffuse, blue–gray spherical cloud
of PEDOT within the brain parenchyma. To examine how the
morphology and kinetics of formation of the PEDOT cloud
varied with increasing amounts of charge, three different wires
were inserted in the same tissue slice and deposition charges
of 45 mC, 90 mC and 135 mC were applied (50 µA for 15,
30 or 45 min, respectively) (figure 2(b)). First, the lateral
extent and then the opacity of the PEDOT cloud increased
systematically with the total charge applied. The pixel density
(measured with ImageJ) of the PEDOT clouds resulting from





Figure 2. A network of conducting PEDOT filaments can be polymerized directly within brain tissue from an implanted electrode. (A) An
image of the set-up used to polymerize PEDOT directly within a mouse brain slice. The tissue slice is physically stabilized within gelatin
then a microwire electrode is inserted into the tissue and a platinum wire reference/counter electrode is inserted into the gelatin. (B) A
mouse brain slice (2 mm thick) within which three distinct PEDOT networks were polymerized from a Au microwire using increasing
polymer deposition charges of 45 mC, 90 mC and 135 mC. (C) A higher magnification image reveals that the PEDOT cloud integrates
directly within the tissue and appears to intensify near and follow white matter fiber tracts (see white stars). (D) High magnification optical
micrograph reveals the microscale structure of the PEDOT filaments within the network and suggests that tissue and extracellular matrix
structures were used as a scaffold for polymerization. These data are representative of similar findings in roughly 20 brain slices in which
PEDOT was polymerized using similar deposition conditions.
91% saturated, respectively. PEDOT clouds could be grown
throughout the brain and we found that the morphology of
the PEDOT fibrils within the cloud appeared to be at least in
part determined by the morphology of the tissue within the
region of the brain in which the PEDOT was polymerized.
This is evident in a higher magnification view of the PEDOT
cloud resulting from the 90 mC polymerization which reveals
localized variations in optical density. These variations are
presumably associated with PEDOT polymerization around
specific structures within the brain tissue such as white matter
tracts which acted as fibrous scaffolds for polymerization (see
∗ (white stars) in figure 2(c)). Furthermore, the 90 mC PEDOT
cloud extended roughly 1 mm out into the tissue, exceeding
the 100–150 µm width of a glial scar that has been found
to form around implanted neural electrodes (Polikov et al
2005) (see figure 2(c)). Higher magnification images near the
electrode–tissue surface indicated that the PEDOT clouds were
actually low-density networks of diffuse PEDOT that appeared
to have grown within the extracellular and interstitial spaces
and polymerized on extracellular matrix (ECM) components
(figure 2(d)). This formed a net of PEDOT fibrils, chains
and filaments woven around and between cells, effectively
innervating the tissue.
PEDOT is not expected to be biodegradable and thus
these conductive polymer networks are permanent, three-
dimensional electrode structures that fill some of the interstitial
spaces and coat ECM components. PEDOT coatings and
networks in gels have been found to be porous at the nano and
microscale; however, it will clearly be necessary to establish
that the presence of the PEDOT networks does not interfere
with diffusion and local mass transport within the brain
tissue that is needed for normal signal transduction and
maintenance of cell viability (Kim et al 2004, Yang et al 2005).
We are currently conducting experiments that assess how the
polymerization procedure and the presence of the filamentous
PEDOT network affects the neurons it contacts and those in the
surrounding tissue. Preliminary studies in which we labeled
cells within the PEDOT clouds with Nissl stain indicate that
cells remain intact following polymerization and that local
diffusion and mass transport were not disrupted by the presence
of the PEDOT. Nissl labels a type of ribosomal RNA which is
abundant within the cytoplasm of healthy neurons and some
glial cells. We found that fluorescent Nissl stain (Molecular
Probes) was taken up by cells within the PEDOT cloud as long
as 3 h following PEDOT polymerization and following a series






Figure 3. Cells within the PEDOT network remain intact and the
PEDOT network is not a barrier to diffusion. (A) Diagram
representing the process of polymerizing PEDOT directly into brain
tissue from a neural electrode device in order to bypass the
surrounding glial scar. (B) An optical micrograph of a PEDOT
cloud deposited directly within brain tissue shows that the
morphology of the brain tissue in the region in which PEDOT is
polymerized affects the morphology of the PEDOT fibrils within the
conductive cloud (see arrows). (C) The same tissue section was then
exposed to fluorescent (red) Nissl stain indicating that the neurons
within the PEDOT cloud are intact following polymerization. These
data are representative of findings in three brain slices which
underwent similar polymerization and staining procedures.
In order to serve as an electrode for an implanted
device, it is necessary that this PEDOT network is
electrically functional and be able to maintain long-term
electrical connectivity while in a physically and biochemically
dynamic environment. It should also be a highly sensitive
electrode that can deliver amounts of charge relevant for
communication with its target cells. To assess these issues,
we performed both electrical impedance spectroscopy (EIS) to
determine electrode impedance and cyclic voltammetry (CV)
to determine charge transfer capacity and identify any redox
reactions that may occur during charge delivery procedures.
A solution of 0.1 M PBS (pH 7.0) was used as the electrolyte
in a three-electrode cell for both EIS and CV. A platinum
foil was used as the counter electrode and a saturated calomel
Ag/AgCl2 electrode was used as the reference electrode. The
PEDOT network electrode was connected to (and became)
the working electrode. The values of the impedance were
determined across frequencies ranging from 1 to 100 000 Hz
and the real and imaginary components of the impedance were
measured as a function of frequency. For CV, a scan rate of
10 mV s−1 was used and the potential on the working electrode
was swept between −1.0 and 1.0 V versus SCE. This limit was
wide enough to include reversible redox reactions yet narrow
enough to avoid over-oxidation and remain within the water
window.
Electrodes were tested before, during and after
polymerization. Similar to results from studies on PEDOT
deposition within low-density hydrogels (Kim et al 2004),
the filamentous PEDOT network deposited within brain tissue
manifests in a large increase in effective surface area of the
electrode as compared to that of the bare electrode as evidenced
by decreased impedance and increased charge capacity. We
found that the decrease in impedance, change in phase angle
and increase in charge capacity of the PEDOT network scaled
according to the total current applied during polymerization,
specifically deposition charges of 45 mC, 90 mC and 135 mC
(see figures 4(a) and (c)). We performed a variety of control
procedures, including application of electrical current in the
absence of monomer solution (in PBS only) and this had little
effect on the impedance or charge capacity of the electrode
(see red lines in figures 4(a)–(c)).
For all three deposition charges, the presence of the
PEDOT network decreased the electrical impedance by
1–2 orders of magnitude and reduced the phase angle of the
impedance from 60◦ for bare wire to about 10◦ (figures 4(a)
and (b)). Previous studies on PEDOT-coated neural electrodes
indicate that similar changes in impedance are associated
with increased electrode conductivity and sensitivity that
result in an increase in signal-to-noise ratio and number of
detectable spikes during in vivo neural recordings (Cui et al
2003, Ludwig et al 2006). Furthermore, biomedical device
electrodes with low impedance generally have lower overall
power requirements (Lanmuller et al 1997, Markewitz et al
1995). For implanted devices this manifests in extended
battery life and provides an opportunity for use of alternative
device power strategies such as telemetry and bio-powering
(Ebron et al 2006, Gorge et al 2001, Neihart and Harrison
2005).
The PEDOT networks within the brain tissue are also
associated with an increase in charge transfer capacity of the
electrode and a dramatic change in shape and symmetry of
the CV curve (figure 4(c)). The increase in area under the
CV curve for the PEDOT networks as compared to the bare
electrode indicates increased charge transfer capabilities and is
likely associated with the increased effective electrode surface
area (Heien et al 2003, Merrill et al 2005). The asymmetric






Figure 4. The filamentous PEDT network polymerized directly
within brain tissue is a functional electrode with lower impedance
and increased charge capacity compared to the bare electrode.
(A) EIS comparing the impedance spectra for the Au microwire
before (open circles) and after insertion into brain tissue (open
triangles) to that of three distinct PEDOT networks polymerized
from the wire into the tissue (increasing deposition charge from
filled circles, filled triangles, to filled squares). For the control
electrical current was applied to the brain tissue via the wire in the
absence of monomer (open squares). (B) The phase angle of the
impedance as detected by EIS. (C) CV curves comparing the charge
capacity for the Au microwire before and after insertion into brain
tissue to that of three distinct PEDOT networks polymerized from
the wire into the tissue and the control. For all electrical analyses, a
platinum wire and foil was used as the counter electrode and a
saturated calomel Ag/AgCl is the reference electrode. These data
are representative of similar findings in roughly ten brain slices in
which PEDOT was polymerized using similar deposition conditions.
within the brain tissue suggest that irreversible Faradaic
reactions are occurring as the current direction is reversed.
This is likely associated with diffusion of electrochemical
species away from the electrode network (Merrill et al
2005) but could also be an indication that the presence of
the PEDOT network reduces ion mobility within the tissue
(Yildiz et al 1999). For reversible Faradaic reactions the
direction of electrochemical reactions are reversed to minimize
unrecoverable charge by maintaining a zero net accumulation
of electrochemical species. In contrast irreversible reactions
are usually associated with reduced charge transfer capacity
due to physical and electrical degradation of the electrode
over time as well as possible tissue damage due to hydrolysis
and oxidation reactions (Halliwell 1992, Merrill et al 2005,
Stohs and Bagchi 1995). Fortunately, a diversity of alternative
electrode stimulation and charge transfer methods that reduce
unrecoverable charge and avoid production of unwanted
electrochemical species are available for use in future studies
of the PEDOT networks. One such method is cycling
the electrode with a charge imbalanced biphasic waveform
which takes into account the probability of irreversible redox
reactions to minimize damage to both the tissue and the
electrode (Merrill et al 2005).
In order to perform in vivo testing and analysis in defined
animal models, a process for polymerizing these polymer
networks within the context of neural electrode devices must
be established. Local monomer delivery to the electrode
sites could be accomplished in a variety of ways such as
by local intracranial injections, infusions through hollow
fibers (Broadhead et al 2002) or microcannulae placed in
the tissue or via devices enabled with microfluidic channels
(Rathnasingham et al 2004). In addition, it will be important
that the fluid delivery method allows for optimization of the
conditions needed to maintain monomer delivery at a rate
consistent with its electrochemical deposition.
Conclusions
Polymerization of PEDOT directly within brain tissue results
in formation of a conductive network that innervates the tissue
and enables uniquely intimate, sensitive contacts between
the electrode and the plasma membranes of neural cells. The
high surface area of these PEDOT networks should facilitate
signal transduction between the ionically conductive tissue and
the electronically conductive device and transport electronic
charge farther out into the tissue, hopefully eliminating the
need to have the neurons near the electrode–tissue interface
where immunoreactions are strongest and the mechanical
stresses and strains are the highest. In addition to these
studies in brain tissue, we also found that functional PEDOT
networks could be polymerized within a variety of other tissues
including dermis and cardiac muscle (data not shown). Due
to the ability to grow within and through nano and micrometer
thin spaces between cells for diameters of as much as
500 µm to 1 mm from the electrode site, this type of conducting
polymer electrode network may be able to penetrate fibrous
scar encapsulations and bypass congregations of immune cells
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that often form around implanted electrodes throughout the
body.
This technology may make possible the establishment
of functional, long-term electrical communication between
implanted biomedical devices and the healthy target cells
tissue despite encapsulation of the device in high electrical
impedance, signal blocking scar tissue. It can be
adapted to create fully-integrated and more efficacious
implanted electrodes for diverse applications such as neural
recording/stimulation, peripheral nerve electrodes, cardiac
anti-arrhythmia devices, muscle stimulation, voltage-mediated
tissue ablation, pH monitoring, glucose sensing, cochlear
implants and retinal prosthetics. In addition, the diffuse,
electrically connected conductive polymer minimizes the
necessity of stiff, sharp immunoreactant metal or alloy-based
devices and signifies a new electrode paradigm built around
an adaptive, filamentous conducting polymer network that
innervates the living tissue.
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